+467.0%
MRNA vs STLA
-40.1%
+507.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STLA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.3% | +3.1% | +3.7% |
| 7D | -1.1% | -2.9% | +1.8% | +1.1% |
| 30D | +126.1% | +0.9% | +125.2% | +125.5% |
| 3M | +190.0% | -21.6% | +211.7% | +201.3% |
| 6M | +157.2% | -21.6% | +178.9% | +168.2% |
| YTD | +388.2% | -50.4% | +438.6% | +433.7% |
| 1Y | +467.0% | -43.6% | +510.6% | +450.2% |
| All | +467.0% | -40.1% | +507.2% | +450.2% |
Cumulative growth
Daily Returns
Daily percentage return beside STLA.
Daily Out/Under-Performance
Portfolio return minus STLA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STLA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling